The Hope Foundation for Cancer Research (@supportingswog.bsky.social)

Lung-MAP 3.0 Expands Genomic Screening Options for Patients | SWOG Lung-MAP is a precision medicine umbrella trial for patients with advanced non-small cell lung cancer (NSCLC), using genomic screening to match patients to investigational new treatments at more than 900 sites across the U.S. As it moves into its second decade, the trial is undergoing another major update (Lung-MAP 3.0) and greatly broadening the list of approved next-generation sequencing (NGS) genomic tests that can be used to assign patients to a targeted Lung-MAP sub-study. https://www.swog.org/news-events/news/2025/04/16/lung-map-30-expands-genomic-screening-options-patients